Coordinated expression and amplification of the MDM2, CDK4, and HMGI‐C genes in atypical lipomatous tumours

Atypical lipomatous tumours (ALTs) represent a distinctive subset of mesenchymal neoplasms featuring mature adipocytic differentiation. Most ALTs are characterized cytogenetically by the presence of supernumerary ring and/or long marker chromosomes derived from the chromosomal region 12q13–15. The 12q13–15 chromosome region contains several genes which may play an important role in human tumorigenesis. A series of ALTs was analysed by investigating the MDM2, CDK4, and HMGI‐C genes and their proteins. The study was extended to a series of ordinary lipomas, to determine whether the immunohistochemical investigation of these gene products might play any diagnostic role. Cytogenetic analysis revealed the presence of various cytogenetic aberrations involving the 12q13–15 region in 11/18 (61%) lipomas and of ring chromosomes in all ALTs. Overexpression of mdm2 protein was observed in 6/12 (50%) atypical lipomatous tumours. All lipomas were mdm2‐negative. cdk4 overexpression was present in 100% of ALTs. Weak cdk4 immunopositivity was detected in 2/18 (11%) ordinary lipomas in a minority of cells. HMGI‐C immunopositivity was observed in 10/12 (83%) ALTs. Positive immunoreactivity was also observed in 8/18 (44%) lipomas. Southern blot analysis revealed amplification of the CDK4 and MDM2 genes in 3/5 ALTs analysed. HMGI‐C was amplified in 3/5 cases and was deleted in one case. Mutation analysis of the CDK4 gene did not demonstrate any mutation. These data support the hypothesis that ordinary lipomas may form a molecular genetic and morphological continuum with ALT. At one end of the spectrum are lipomas characterized by 12q13–15 rearrangements and HMGI‐C activation and at the other end are ALTs with ring chromosomes, 12q13–15 amplification with overrepresentation of the HMGI‐C, CDK4 or MDM2 genes, and aberrant cdk4, mdm2, and HMGI‐C protein expression. These findings not only provide insights into the molecular pathogenesis of lipomatous tumours, but also indicate that the immunohistochemical analysis of mdm2 and cdk4 may help to increase diagnostic accuracy. Copyright © 2000 John Wiley & Sons, Ltd.

[1]  F. Collin,et al.  Structure of the supernumerary ring and giant rod chromosomes in adipose tissue tumors , 1999, Genes, chromosomes & cancer.

[2]  A. D. Dei Tos,et al.  Amplification and expression of the HMGIC gene in a benign endometrial polyp , 1998, Genes, chromosomes & cancer.

[3]  F. Rilke,et al.  Molecular abnormalities in liposarcoma: role of MDM2 and CDK4‐containing amplicons at 12q13–22 , 1998, The Journal of pathology.

[4]  A. D. Dei Tos,et al.  Molecular aberrations of the G1-S checkpoint in myxoid and round cell liposarcoma. , 1997, American Journal of Pathology.

[5]  Yan A. Su,et al.  Characterization of a highly conserved gene (OS4) amplified with CDK4 in human sarcomas , 1997, Oncogene.

[6]  P. Rogalla,et al.  Expression of HMGI‐C, a member of the high mobility group protein family, in a subset of breast cancers: Relationship to histologic grade , 1997, Molecular carcinogenesis.

[7]  R. Sciot,et al.  Expression of HMGI-C and HMGI(Y) in ordinary lipoma and atypical lipomatous tumors: immunohistochemical reactivity correlates with karyotypic alterations. , 1997, The American journal of pathology.

[8]  D. Dickson.  Discovery of new lesions in neurodegenerative diseases with monoclonal antibody techniques: is there a non-amyloid precursor to senile plaques? , 1997, The American journal of pathology.

[9]  O. Myklebost,et al.  HMGIC, the gene for an architectural transcription factor, is amplified and rearranged in a subset of human sarcomas , 1997, Oncogene.

[10]  R. Maestro,et al.  p16/CDKN2 and CDK4 gene mutations in sporadic melanoma development and progression , 1997, International journal of cancer.

[11]  A. D. Dei Tos,et al.  MOLECULAR ABNORMALITIES OF THE p53 PATHWAY IN DEDIFFERENTIATED LIPOSARCOMA , 1997 .

[12]  F. Rilke,et al.  DISTINCT mdm2/p53 EXPRESSION PATTERNS IN LIPOSARCOMA SUBGROUPS: IMPLICATIONS FOR DIFFERENT PATHOGENETIC MECHANISMS , 1997, The Journal of pathology.

[13]  C. Sherr.  Cancer Cell Cycles , 1996, Science.

[14]  P. Meltzer,et al.  Separate amplified regions encompassing CDK4 and MDM2 in human sarcomas , 1996, Genes, chromosomes & cancer.

[15]  M. Bittner,et al.  Molecular cytogenetic characterization and physical mapping of 12q13–15 amplification in human cancers , 1996, Genes, chromosomes & cancer.

[16]  F. Mitelman,et al.  Combined morphologic and karyotypic study of 59 atypical lipomatous tumors. Evaluation of their relationship and differential diagnosis with other adipose tissue tumors (a report of the CHAMP Study Group). , 1996, The American journal of surgical pathology.

[17]  F. Mitelman,et al.  Duplication of chromosome segment 12q15‐24 is associated with atypical lipomatous tumors. A report of the CHAMP collaborative study group , 1996, International journal of cancer.

[18]  P. Rogalla,et al.  HMGI-C expression patterns in human tissues. Implications for the genesis of frequent mesenchymal tumors. , 1996, The American journal of pathology.

[19]  R. Kucherlapati,et al.  Translocation breakpoints upstream of the HMGIC gene in uterine leiomyomata suggest dysregulation of this gene by a mechanism different from that in lipomas , 1996, Genes, chromosomes & cancer.

[20]  A. D. Dei Tos,et al.  Tumor suppressor genes and related molecules in leiomyosarcoma. , 1996, The American journal of pathology.

[21]  F. Mitelman,et al.  Correlation between clinicopathological features and karyotype in lipomatous tumors. A report of 178 cases from the Chromosomes and Morphology (CHAMP) Collaborative Study Group. , 1996, The American journal of pathology.

[22]  W. V. D. Van de Ven,et al.  HMGI-C rearrangements as the molecular basis for the majority of pulmonary chondroid hamartomas: a survey of 30 tumors. , 1996, Oncogene.

[23]  N. Hayward,et al.  Germline mutations in the p16INK4a binding domain of CDK4 in familial melanoma , 1996, Nature Genetics.

[24]  C. Fletcher,et al.  Soft Tissue Tumors , 1995, Current Topics in Pathology.

[25]  R. Lovell-Badge.  Living with bad architecture , 1995, Nature.

[26]  Herman Van den Berghe,et al.  Recurrent rearrangements in the high mobility group protein gene, HMGI-C, in benign mesenchymal tumours , 1995, Nature Genetics.

[27]  J. Fletcher,et al.  Disruption of the architectural factor HMGI-C: DNA-binding AT hook motifs fused in lipomas to distinct transcriptional regulatory domains , 1995, Cell.

[28]  W. Sellers,et al.  Interaction between the retinoblastoma protein and the oncoprotein MDM2 , 1995, Nature.

[29]  Tony Kouzarides,et al.  Stimulation of E2F1/DP1 transcriptional activity by MDM2 oncoprotein , 1995, Nature.

[30]  R. Maestro,et al.  MDM2 overexpression does not account for stabilization of wild-type p53 protein in non-Hodgkin's lymphomas. , 1995, Blood.

[31]  P. Meltzer,et al.  Genomic structure of SAS, a member of the transmembrane 4 superfamily amplified in human sarcomas. , 1995, Genomics.

[32]  A. Marchetti,et al.  mdm2 gene alterations and mdm2 protein expression in breast carcinomas , 1995, The Journal of pathology.

[33]  C. Fletcher,et al.  Translocation t(12;16)(q13;p11) in myxoid liposarcoma and round cell liposarcoma: molecular and cytogenetic analysis. , 1995, Cancer research.

[34]  A. Levine,et al.  Molecular abnormalities of mdm2 and p53 genes in adult soft tissue sarcomas. , 1994, Cancer research.

[35]  A. Look,et al.  Coamplification of the CDK4 gene with MDM2 and GLI in human sarcomas. , 1993, Cancer research.

[36]  P. Cin,et al.  Cytogenetic and fluorescence in situ hybridization investigation of ring chromosomes characterizing a specific pathologic subgroup of adipose tissue tumors. , 1993, Cancer genetics and cytogenetics.

[37]  P. Meltzer,et al.  p53 Mutation and MDM2 amplification in human soft tissue sarcomas. , 1993, Cancer research.

[38]  F. Mitelman,et al.  Rearrangement of the transcription factor gene CHOP in myxoid liposarcomas with t(12;16)(q13;p11) , 1992, Genes, chromosomes & cancer.

[39]  P. Meltzer,et al.  Amplification of a gene encoding a p53-associated protein in human sarcomas , 1992, Nature.

[40]  P. Cary,et al.  cDNA cloning of the HMGI-C phosphoprotein, a nuclear protein associated with neoplastic and undifferentiated phenotypes. , 1991, Nucleic acids research.

[41]  P. Meltzer,et al.  Identification and cloning of a novel amplified DNA sequence in human malignant fibrous histiocytoma derived from a region of chromosome 12 frequently rearranged in soft tissue tumors. , 1991, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[42]  J. Trent,et al.  Identification of an amplified, highly expressed gene in a human glioma. , 1987, Science.

[43]  F. Enzinger,et al.  Soft tissue tumors , 1988 .

[44]  R. Winkelmann,et al.  Atypical lipoma, atypical intramuscular lipoma, and well differentiated retroperitoneal liposarcoma. A reappraisal of 30 cases formerly classified as well differentiated liposarcoma , 1979, Cancer.